BESTING THE BLACK-BOX: BARRIER ZONES FOR ADVERSARIAL EXAMPLE DEFENSE



Current treatment paradigms and emerging therapies for NAFLD/NASH

Non-alcoholic fatty liver disease (NAFLD) is one the fastest emerging manifestations of the metabolic syndrome worldwide.Non-alcoholic steatohepatitis (NASH), the progressive form of NAFLD, may culminate into cirrhosis and hepatocellular cancer (HCC) and is presently a leading cause Potassium of liver transplant.Although a steady progress is seen i

read more

Free Fatty Acid Concentration and Carboxy methyl cellulase Activity of Some Formulas of Protected Fat-proteins Tested In Vitro

The aim of this study was to determine the levels of free fatty acids and carboxymethylcellulase activity (cmc-ase) activity of some protected fat-proteins base on in vitro Tilley and Terry method.Two sources of fat, i.e.crude palm oil and fish oil and three sources of protein i.e.skim milk, soybean flour and soybean meal were used in ROSEMARY COND

read more